Detalhe da pesquisa
1.
Standardized intraoperative application of an absorbable polysaccharide hemostatic powder to reduce the incidence of lymphocele after kidney transplantation - a prospective trial.
Transpl Int
; 32(1): 59-65, 2019 01.
Artigo
em Inglês
| MEDLINE | ID: mdl-30099769
2.
Fibroblast growth factor receptor 3 isoforms: Novel therapeutic targets for hepatocellular carcinoma?
Hepatology
; 62(6): 1767-78, 2015 Dec.
Artigo
em Inglês
| MEDLINE | ID: mdl-26235436
3.
TP53 germline mutation may affect response to anticancer treatments: analysis of an intensively treated Li-Fraumeni family.
Breast Cancer Res Treat
; 151(3): 671-8, 2015 Jun.
Artigo
em Inglês
| MEDLINE | ID: mdl-25981898
4.
Up-regulation of the fibroblast growth factor 8 subfamily in human hepatocellular carcinoma for cell survival and neoangiogenesis.
Hepatology
; 53(3): 854-64, 2011 Mar.
Artigo
em Inglês
| MEDLINE | ID: mdl-21319186
5.
TP53 is not a prognostic marker-clinical consequences of a generally disregarded fact.
Ann N Y Acad Sci
; 1434(1): 46-53, 2018 12.
Artigo
em Inglês
| MEDLINE | ID: mdl-30112858
6.
⢠Pancho trial (p53-adapted neoadjuvant chemotherapy for resectable esophageal cancer) completed-mutation rate of the marker higher than expected.
Eur Surg
; 50(4): 160-166, 2018.
Artigo
em Inglês
| MEDLINE | ID: mdl-30559831
7.
Genetic detection of lymph node micrometastases: a selection criterion for liver transplantation in patients with liver metastases after colorectal cancer.
Transplantation
; 81(1): 64-70, 2006 Jan 15.
Artigo
em Inglês
| MEDLINE | ID: mdl-16421478
8.
Stage-directed individualized therapy in esophageal cancer.
Ann N Y Acad Sci
; 1381(1): 50-65, 2016 10.
Artigo
em Inglês
| MEDLINE | ID: mdl-27384385
9.
Pattern of hormone receptor status of secondary contralateral breast cancers in patients receiving adjuvant tamoxifen.
Clin Cancer Res
; 8(11): 3427-32, 2002 Nov.
Artigo
em Inglês
| MEDLINE | ID: mdl-12429630
10.
TP53 Mutational Status and Prediction of Benefit from Adjuvant 5-Fluorouracil in Stage III Colon Cancer Patients.
EBioMedicine
; 2(8): 825-30, 2015 Aug.
Artigo
em Inglês
| MEDLINE | ID: mdl-26425688
11.
Young age as an independent adverse prognostic factor in premenopausal patients with breast cancer.
Clin Breast Cancer
; 3(1): 65-72, 2002 Apr.
Artigo
em Inglês
| MEDLINE | ID: mdl-12020397
12.
Prognostic markers in breast cancer: the reliability of HER2/neu status in core needle biopsy of 325 patients with primary breast cancer.
Wien Klin Wochenschr
; 116(1-2): 26-31, 2004 Jan 31.
Artigo
em Inglês
| MEDLINE | ID: mdl-15030120
13.
The biomarker TP53 divides patients with neoadjuvantly treated esophageal cancer into 2 subgroups with markedly different outcomes. A p53 Research Group study.
J Thorac Cardiovasc Surg
; 148(5): 2280-6, 2014 Nov.
Artigo
em Inglês
| MEDLINE | ID: mdl-25135238
14.
Strategy for prevention of cancers of the esophagus.
Ann N Y Acad Sci
; 1325: 108-26, 2014 Sep.
Artigo
em Inglês
| MEDLINE | ID: mdl-25266020
15.
Cytosine 5-Hydroxymethylation of the LZTS1 Gene Is Reduced in Breast Cancer.
Transl Oncol
; 6(6): 715-21, 2013 Dec 01.
Artigo
em Inglês
| MEDLINE | ID: mdl-24466374
16.
Barrett's esophagus: treatments of adenocarcinomas II.
Ann N Y Acad Sci
; 1232: 265-91, 2011 Sep.
Artigo
em Inglês
| MEDLINE | ID: mdl-21950818
17.
NORE1B is a putative tumor suppressor in hepatocarcinogenesis and may act via RASSF1A.
Cancer Res
; 69(1): 235-42, 2009 Jan 01.
Artigo
em Inglês
| MEDLINE | ID: mdl-19118008
18.
HB-EGF is a paracrine growth stimulator for early tumor prestages in inflammation-associated hepatocarcinogenesis.
J Hepatol
; 49(6): 955-64, 2008 Dec.
Artigo
em Inglês
| MEDLINE | ID: mdl-18929421
19.
Growing clinical evidence for the interaction of the p53 genotype and response to induction chemotherapy in advanced non-small cell lung cancer.
J Thorac Cardiovasc Surg
; 135(5): 1036-41, 2008 May.
Artigo
em Inglês
| MEDLINE | ID: mdl-18455581
20.
Downregulation of TSLC1 and DAL-1 expression occurs frequently in breast cancer.
Breast Cancer Res Treat
; 103(3): 283-91, 2007 Jul.
Artigo
em Inglês
| MEDLINE | ID: mdl-17260099